Fate Therapeutics Reports Fourth Quarter 2019 Financial Results and Operational Progress with 2020 Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. IBM
4. META
5. DPZ
6. DFTX
7. CNC
8. KFY
9. SPY
10. MU

Go back to Fate Therapeutics Reports Fourth Quarter 2019 Financial Results and Operational Progress with 2020 Outlook

Fate Therapeutics (FATE) Tops Q4 EPS by 2c

March 2, 2020 4:05 PM EST

Fate Therapeutics (NASDAQ: FATE) reported Q4 EPS of ($0.37), $0.02 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $2.8 million versus the consensus estimate of $1.8 million.

For earnings history and earnings-related data on Fate Therapeutics (FATE) click here.

... More